Polyclonal Rabbit anti‑Human CDC25A Antibody (phospho‑Ser75, IHC, WB) LS‑C5907
Polyclonal Rabbit anti‑Human CDC25A Antibody (phospho‑Ser75, IHC, WB) LS‑C5907
Antibody:
CDC25A Rabbit anti-Human Polyclonal (pSer75) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
CDC25A Rabbit anti-Human Polyclonal (pSer75) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
CDC25A antibody LS-C5907 is an unconjugated rabbit polyclonal antibody to CDC25A (pSer75) from human. Validated for IHC and WB.
Target
Human CDC25A
Synonyms
CDC25A | CDC25A2-CAG isoform | Cell division cycle 25A | CDC25A phosphatase | CDC25Hu1 | M-phase inducer phosphatase 1 | CDC25A2
Conjugations
Unconjugated.
Also available conjugated with
APC,
Biotin,
FITC,
HRP,
PE.
Modifications
Unmodified.
Also available
Azide-free.
Specificity
This CDC25A Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S75 of human CDC25A.
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Storage
Short term: 4°C; Long term: Add glycerol (40-50%) -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human, Mouse, Rat
Range:
Positive/Negative
Source:
E. coli
Tag:
6His, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/24/2024